Mizuho analyst Ann Hynes lowered the firm’s price target on Acadia Healthcare (ACHC) to $37 from $48 and keeps a Neutral rating on the shares. The firm sees continued volume pressures for Acadia following its reduced long-term outlook. Mizuho does not believe the shares can trade at their previous multiple until the company generates positive free cash flow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare price target lowered to $43 from $64 at RBC Capital
- Acadia Healthcare price target lowered to $65 from $70 at KeyBanc
- Strategic Growth Amidst Challenges: Whit Mayo’s Buy Rating on Acadia Healthcare
- Acadia Healthcare price target lowered to $40 from $44.50 at BofA
- Acadia Healthcare Reports Strong Q4 2024 Results